midazolam has been researched along with Anemia in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granberg Axèll, AI | 1 |
| Malmros, CW | 1 |
| Bergbom, IL | 1 |
| Lundberg, DB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery[NCT03847155] | 52 participants (Actual) | Interventional | 2015-09-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for midazolam and Anemia
| Article | Year |
|---|---|
Intensive care unit syndrome/delirium is associated with anemia, drug therapy and duration of ventilation treatment.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Anemia; Delirium; Female; Fentanyl; | 2002 |